Otros idiomas D. Western Therapeutics Institute, Inc.

Acciones

4576

JP3548740004

Mercado cerrado - Japan Exchange Otros sitios de cotización 08:00:00 02/05/2024			Varia. Cinco días.	Varia. 1 de enero.
110 ^JPY	+4,76 %		+4,76 %	-21,99 %

14/02	D. Western Therapeutics Institute, Inc. ofrece una previsión de beneficios consolidados y no consolidados para todo el año que finaliza el 31 de diciembre de 2024	CI
2023	D. Western Therapeutics Institute, Inc. ofrece una previsión de beneficios consolidados para todo el año que finaliza el 31 de diciembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

D. Western Therapeutics Institute, Inc. Provides Consolidated and Non Consolidated Earnings Guidance for the Full Year Ending December 31, 2024	14/02
D. Western Therapeutics Institute, Inc. Provides Consolidated Earnings Guidance for the Full Year Ending December 31, 2023	10/08/23
D Western Therapeutics Institute : Summary of Consolidated Financial Results for the Six Months Ended June 30, 2023(Based on Japanese GAAP)	10/08/23
D. Western Therapeutics Institute, Inc. Provides Consolidated Earnings Guidance for the Full Year Ending December 31, 2024	15/05/23
D. Western Therapeutics Institute, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23
D. Western Therapeutics Institute, Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2023	14/02/23
D Western Therapeutics Institute : FY12/22 Financial Results Briefing Materials	13/02/23
D. Western Therapeutics Institute, Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2022	11/11/22
D. Western Therapeutics Institute, Inc. announced that it has received ¥901.216203 million in funding from Whiz Partners Inc.	19/07/22
D. Western Therapeutics Institute, Inc. announced that it expects to receive ¥901.216203 million in funding from Whiz Partners Inc.	20/06/22
D. Western Therapeutics Institute, Inc. Provides Earnings Guidance for the Fiscal Year Ending December 31, 2022	13/05/22
D Western Therapeutics Institute : Summary of Consolidated Financial Results for the Year Ended December 31, 2021(Based on Japanese GAAP)	14/02/22
D. Western Therapeutics Institute, Inc. Provides Earnings Guidance for the Fiscal Year Ending December 31, 2022	14/02/22
D. Western Therapeutics Institute, Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2021	12/11/21
D. Western Therapeutics Institute, Inc. Announces Consolidated Earnings Results for the Six Months Ended June 30, 2021	11/08/21
D. Western Therapeutics Institute, Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2021	11/08/21
UBiENCE Inc. announced that it expects to receive ¥100 million in funding from D. Western Therapeutics Institute, Inc.	17/06/21
D. Western Therapeutics Institute, Inc. Reports Consolidated Financial Results for the First Quarter Ended March 31, 2021	13/05/21
D. Western Therapeutics Institute, Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2021	13/05/21
D. Western Therapeutics Institute, Inc. Reports Consolidated Financial Results for the Year Ended December 31, 2020	12/02/21

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas D. Western Therapeutics Institute, Inc.

Acciones

4576

JP3548740004

Otros idiomas

Filtros